striatum

  1. forestglip

    Astrogliosis Marker [11C]SL25.1188 After COVID-19 With Ongoing Depressive and Cognitive Symptoms, 2025, Braga et al

    Astrogliosis Marker [11C]SL25.1188 After COVID-19 With Ongoing Depressive and Cognitive Symptoms Background After acute COVID-19, 5% of people experience persistent depressive symptoms and reduced cognitive function (COVID-DC). Theoretical models propose that astrogliosis is important in long...
  2. Nightsong

    Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptoms, 2026, Liu et al

    Abstract: Background Dopaminergic neurons are vulnerable to injury from gliosis and have high density of ACE2 receptors, but the integrity of dopaminergic neurons has not been investigated in long COVID. This study examined whether vesicular monoamine transporter 2 (VMAT2) binding, index of...
  3. hotblack

    Simulations of Direct Pathway MSNs Investigate the Fast Onset of Dopaminergic Effects and Predict the Role of Kv4.2, 2018, Lindroos et al

    Basal Ganglia Neuromodulation Over Multiple Temporal and Structural Scales—Simulations of Direct Pathway MSNs Investigate the Fast Onset of Dopaminergic Effects and Predict the Role of Kv4.2 Abstract The basal ganglia are involved in the motivational and habitual control of motor and...
  4. forestglip

    [Abstract] Integrity of Presynaptic Neurons in Long COVID and Relationship to Neuropsychiatric Symptoms, 2026, Liu et al

    Integrity of Presynaptic Neurons in Long COVID and Relationship to Neuropsychiatric Symptoms Yuhan Liu, Devina Persaud, Erica Vieira, Joeffre Braga, Pablo Rusjan, Laura Miler, Jennifer Rabin, Tina Mccluskey, Isabelle Boileau, Thomas Chao, Michael Bagby, Lucas Narciso, Lauren Gray, Neil Vasdev...
Back
Top Bottom